Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

Condition: Inflammatory bowel disease

Category: Gastroenterology

Type: Article

Date: 2018

Author: Mitchell R. K. L. Lie

Demonstrated that LDN directly improves epithelial barrier function by improving wound healing and reducing mucosal ER stress levels. Low dose Naltrexone treatment is effective and safe, and could be considered for the treatment of therapy refractory IBD patients.

Not Finding What You're Looking For?

Fill out the form below to let us know.

>